Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study | Journal of Clinical Oncology https://t.co/lvaSghwssa
3,028 followers
4,623 followers
New2Trip: Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4 yr Results & Evaluation of Impact of Genomic Complexity & Gene Mutations From MURANO Phase III Study https://t.co/HCA3eYvuzj
858 followers
@marcellorotta1 @EghtedarAli @MichaelMaris8 @LukeMtjoy
50,525 followers